Tarbox Family Office, Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tarbox Family Office, Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2022$12,000
+9.1%
8050.0%0.00%0.0%
Q4 2021$11,000
-15.4%
8050.0%0.00%0.0%
Q3 2021$13,000
-7.1%
8050.0%0.00%
-33.3%
Q2 2021$14,000
-6.7%
8050.0%0.00%0.0%
Q1 2021$15,0000.0%8050.0%0.00%0.0%
Q4 2020$15,000
+7.1%
8050.0%0.00%0.0%
Q3 2020$14,0000.0%8050.0%0.00%
-25.0%
Q2 2020$14,000
+16.7%
8050.0%0.00%0.0%
Q1 2020$12,000
-25.0%
8050.0%0.00%0.0%
Q4 2019$16,000
+14.3%
8050.0%0.00%0.0%
Q3 2019$14,0000.0%8050.0%0.00%0.0%
Q2 2019$14,000
-12.5%
8050.0%0.00%
-33.3%
Q1 2019$16,0008050.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders